K. Willey

发表

Indapamide is as effective as captopril in the control of microalbuminuria in diabetes.

D. Yue, L. Molyneaux, K. Willey, 1996, Journal of cardiovascular pharmacology.

Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.

R. Donnelly, D. Yue, L. Molyneaux, 1996, The American journal of cardiology.

Does insulin therapy have a hypertensive effect in type 2 diabetes?

D. Yue, R. Zilkens, L. Molyneaux, 1998, Journal of cardiovascular pharmacology.

High-performance liquid chromatographic preparation of single-site carrier-free pancreatic polypeptide hormone radiotracers.

B. Frank, K. Willey, M. Beckage, 1983, Journal of chromatography.

Albuminuria is an Independent Predictor of Carotid Intima-Media Thickness and Atherosclerosis in NIDDM Patients

D. Yue, R. Assan, John P Harris, 1995, Diabetes Care.

The Effects of Dexfenfluramine on Blood Glucose Control in Patients with Type 2 Diabetes

J. Overland, L. Molyneaux, K. Willey, 1992, Diabetic medicine : a journal of the British Diabetic Association.

Obese Patients with Type 2 Diabetes Poorly Controlled by Insulin and Metformin: Effects of Adjunctive Dexfenfluramine Therapy on Glycaemic Control

D. Yue, L. Molyneaux, K. Willey, 1994, Diabetic medicine : a journal of the British Diabetic Association.

Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.

D. Sullivan, J. Gebicki, K. Willey, 1992, Biochemical pharmacology.

Battling insulin resistance in elderly obese people with type 2 diabetes: bring on the heavy weights.

Maria A. Fiatarone Singh, K. Willey, 2003, Diabetes care.

Single-Visit Screening of Diabetic Complications

M. McGill, D. Yue, W. Plehwe, 1989, Diabetes Care.